Judge Sleet Issues Markman Opinion In Infringement Action Construing Seven (7) Disputed Terms In Patents-In-Suit

Who We Are

With bold growth, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a national law firm combined with the personal touch and connections of a boutique firm.

Our Mission

Solving problems is our top priority. We invest the time to get to know you and understand your needs. We work hard to win every client’s loyalty. We do that by providing creative solutions and excellent client service.

Explore Firm Details

In Forest Laboratories, LLC, et al. v. Apotex Corp., et al., the Court rendered its Markman opinion construing seven disputed terms in U.S. Patent Nos. 6,417,175 ("the ‘175 patent") and 8,247,400.

United States Intellectual Property

Gregory B. Williams

Your Author LinkedIn Connections

Article Insights

Fox Rothschild LLP are most popular:

in South America

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Forest Laboratories, LLC, et al. v. Apotex Corp., et al., Civil Action No. 15-018-GMS (D.Del., November 8, 2016) (consolidated), the Court rendered its Markman opinion construing seven (7) disputed terms in U.S. Patent Nos. 6,417,175 ("the '175 patent") and 8,247,400 ("the '400 patent"). The patents-in-suit relate to new cephem compounds useful for the treatment of bacterial infections and pharmaceutical compositions containing the compounds.

A copy of the Memorandum Opinion is attached.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Authors

Gregory B. Williams

Your Author LinkedIn Connections

See More Popular Content From

Judge Sleet Issues Markman Opinion In Infringement Action Construing Seven (7) Disputed Terms In Patents-In-Suit

Contributor

Intellectual Property

Contributor

United States